Columbus

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Immune thrombocytopenia (ITP)1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Octapharma2 trials

Closed trials

• Completed

  Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

  NCT04502030· Phase 3· Octapharma· Source

• Terminated

  Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)

  NCT03866798· Phase 4· Octapharma· Source